Tech Company Financing Transactions

SamanTree Medical Funding Round

SamanTree Medical, operating out of Lausanne, received $14 million in funding from Relyens, b2venture and BOM.

Transaction Overview

Company Name
Announced On
7/16/2024
Transaction Type
Venture Equity
Amount
$14,000,000
Round
Series B
Proceeds Purpose
The company intends to use the funds to further develop and commercialize the Histolog® Scanner, expand its reach in Europe and the United States, and enhance its digital suite.

Company Information

Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
Avenue de Provence 12
Lausanne, 1007
Switzerland
Email Address
Overview
SamanTree Medical is born out of a novel ultra-fast confocal microscopy technology invented at EPFL (Switzerland) in 2010. This innovation has found its application in cancer treatment, where it enables medical professionals to identify and remove cancerous tissue with unique accuracy and speed. By allowing for real-time imaging from biopsy taking to intraoperative decision making, this technology can help to improve patient treatment plans and outcomes, making it a crucial tool in the fight against cancer.
Profile
SamanTree Medical LinkedIn Company Profile
Social Media
SamanTree Medical Company Twitter Account
Company News
SamanTree Medical News
Facebook
SamanTree Medical on Facebook
YouTube
SamanTree Medical on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Olivier Delporte
  Olivier Delporte LinkedIn Profile  Olivier Delporte Twitter Account  Olivier Delporte News  Olivier Delporte on Facebook
Chief Marketing Officer
François Mange
  François Mange LinkedIn Profile  François Mange Twitter Account  François Mange News  François Mange on Facebook
Chief Technical Officer
Etienne Shaffer
  Etienne Shaffer LinkedIn Profile  Etienne Shaffer Twitter Account  Etienne Shaffer News  Etienne Shaffer on Facebook
VP - Engineering
Andrey Naumenko
  Andrey Naumenko LinkedIn Profile  Andrey Naumenko Twitter Account  Andrey Naumenko News  Andrey Naumenko on Facebook
VP - Finance
Vanessa Degano
  Vanessa Degano LinkedIn Profile  Vanessa Degano Twitter Account  Vanessa Degano News  Vanessa Degano on Facebook
VP - Regulatory Affairs
Jozef Tanczos
  Jozef Tanczos LinkedIn Profile  Jozef Tanczos Twitter Account  Jozef Tanczos News  Jozef Tanczos on Facebook
VP - Sales
Cédric Trabucatti
  Cédric Trabucatti LinkedIn Profile  Cédric Trabucatti Twitter Account  Cédric Trabucatti News  Cédric Trabucatti on Facebook


 

 

Browse more venture capital transactions:

Prev: 7/16/2024: doinstruct venture capital transaction
Next: 7/16/2024: PEXX venture capital transaction

 

Share this article

 


Where The Data Comes From

We report on every notable VC transaction. VC investment data records reported here are derived from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary